Nuntius Therapeutics

Cell-specific genetic medicines

Nuntius Therapeutics was founded in 2021, is headquartered in London, United Kingdom, lists 1–10 employees, and has 1 recorded funding round.

Headquarters
London
Employees
1–10
Founded
2021
Last Round
Pre-SeedJan 2021
Rounds
1

Indexed holds 1 funding round and 4 investors for this company. The full record is or through the API.

About

Nuntius Therapeutics develops mRNA therapies for patients with life-threatening diseases using proprietary delivery technology, machine learning and nucleic acid engineering. Its programmable nanocarriers target tissues and cell types beyond the liver, while trained models guide carrier selection. Its therapy pipeline focuses on cancer, lung diseases and neurodegenerative diseases.

Summary

Nuntius Therapeutics is a Biotech company based in London, United Kingdom, founded in 2021. It lists 1–10 employees. Its most recent funding was a Pre-Seed round in Jan 2021. Investors include Asymmetry Ventures, Backed and FoundersX Ventures.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Pre-seedPre-Seed2021 (est.)

Investors

Similar Companies

Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Nuntius Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/nuntius-therapeutics"><img src="https://indexed.vc/api/badge/company/nuntius-therapeutics" alt="Nuntius Therapeutics on Indexed.vc" width="260" height="76" /></a>